转化生长因子α对LoVo细胞增殖及其它生物学功能影响的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:转化生长因子α(TGF-α)是由50个氨基酸残基构成的一类小分子多肽,其广泛存在于人体多种器官和体液中,研究表明TGF-α对人体胃肠道功能起着重要的调节作用,能够刺激人体胃肠道细胞的生长和分化,对胃肠道粘膜损伤具有修复和保护的功能,并可促进新生儿胃肠道的生长发育。
     本课题旨在研究人初乳、常乳及婴儿配方乳源性及重组人转化生长因子α(TGF-α)对人结肠上皮细胞LoVo促增殖作用,以及不同浓度外源性TGF-α对LoVo细胞RNA和蛋白质含量及细胞迁移能力的影响。
     方法:以人结肠细胞LoVo为研究模型,采用四甲基偶氮唑盐比色法(MTT法)检测人初乳、常乳、婴儿配方乳粉和重组人TGF-α(浓度分别为0.1、1、10和100ng/mL)作用人结肠上皮细胞模型24h后细胞增殖率的变化,以及各成分添加TGF-α抗体作用24h后人结肠上皮细胞模型增殖率的变化。
     分别添加重组人TGF-α0.1、1(接近人乳TGF-α含量最低值)、10(接近人乳TGF-α含量最高值)、100ng/mL后,观察LoVo细胞增殖能力、细胞总RNA、总蛋白质含量以及细胞迁移能力的变化。
     结果:各种成分乳以及不同浓度重组人转化生长因子α均能够显著提高人结肠上皮细胞增殖率。并且随着TGF-α浓度的升高细胞增殖程度也相应得到提高。而TGF-α抗体的中和作用使得重组人TGF-α对肠上皮细胞促增殖作用在四个浓度组中分别降低了11±3.2%(P<0.05)、12±0.3%(P<0.05)、3±2.1%(P>0.05)和4±3.3%(P>0.05),同时也使得人初乳、常乳以及婴儿配方乳粉对肠上皮细胞促增殖作用分别降低了56±13%(P<0.01)、35±3%(P<0.05)和9±3%(P>0.05)。
     添加TGF-α24小时后,细胞较对照组有明显的增殖现象,且细胞增殖率随细胞浓度增加而呈上升趋势,并在10ng/mL时达到最大(P<0.01)。添加TGF-α48小时后,细胞增殖率依然随TGF-α浓度增大而依次升高,且在100ng/mL时达到最大(P<0.01)。而48h与24h相比细胞增殖率有所提高,说明增殖率与TGF-α成一定的时间依赖关系。
     细胞总RNA含量随TGF-α浓度增加而上升为控制组的1.67倍(P<0.05)至4.20倍(P<0.01)。而100ng/mL组细胞总蛋白质含量明显高于控制组和其它各剂量组。为对照组的1.28倍(P<0.05)。另外,添加重组人TGF-α与对照组相比可明显提高LoVo细胞迁移能力。
     结论:TGF-α抗体对含有人初乳、常乳和基于牛乳成分的婴儿配方乳粉以及重组人TGF-α培养基的中和作用使得它们对人结肠上皮细胞的促增殖作用显著降低,证明不同源性的TGF-α都能够对人体外肠道上皮细胞起到明显的促增殖作用。
     外源性TGF-α同样能够促进人结肠上皮细胞RNA含量的增加和蛋白质的合成。并且提高LoVo细胞的迁移能力。
Objective:transforming growth factor-alpha(TGF-α) is a small 50 amino acid residue long mitogenic protein,It generally exist in many human organs and body fluids.Studies confirm that TGF-αcan accommodate gastrointestinal tract physiologic function,suscitate proliferation and differentiation of gastrointestinal tract cells.It also can repair and protect the membrana mucosa of human gastrointestinal tract,and stimulate the growth and development in gastrointestinal tract of infant.
     In our study,we try to explore the proliferation effects of transforming growth factor-alpha from human colostrum,natural human milk,infant formula milk powder and recombinant transforming growth factor-alpha(TGF-α) on human colon epidermal cell model(LoVo) cells.And to investigate the effect of transforming growth factorα(TGF-α) on growth,total cellular RNA and protein also the ransference capability of human colon(LoVo) cells.
     Methods:Using MTT to assay the effects of human colostrums,natural human milk,infant formula milk powder and recombinant TGF-α(0.1,1,10 and 100ng/mL) on human colon epidermal LoVo cell proliferation in the presence or absence of TGF-αantibody.
     And the effects of proliferation,total cellular RNA and protein also the immigration capability of LoVo cells' were examined after the addition of TGF-αat 0.1,1(close to TGF-αmin concentration in human milk),10(close to TGF-αmax concentration inhuman milk) or 100ng/mL.
     Results:Whether human colostrum,natural human milk,infant formula milk powder or recombinant TGF-αcan significant stimulate the proliferation of human colon epidermal cell.And there was a dose-dependent effect of TGF-αon cell proliferation.The stimulatory effect of TGF-αwas decreased in the presence of TGF-αantibody 11±3.2%(P<0.05),12±0.3%(P<0.05),3±2.1% (P>0.05) and 4±3.3%(P>0.05).In the presence of TGF-αantibody there was a 56±13%decline in colostrum stimulated growth(P<0.01),and a 35±3%decline in natural human milk stimulated growth(P<0.05),and a 9±3%decline in infant formula milk powder stimulated growth(P>0.05).
     After incubation with TGF-αfor 24 h,there was a significant proliferation of LoVo cells by concentration of TGF-αwere increased.The proliferation came to the top when concentration of TGF-αwere at 10ng/mL(P<0.01).And after incubation with TGF-αfor 48 h,there was also a significant proliferation increased of LoVo cells by concentration of TGF-α.,and the proliferation came to the top when concentration of TGF-αwere at 100ng/mL(P<0.01).And the 48h proliferation was bigger than 24h proliferation of LoVo cells.So the proliferation can increased by the time.
     And the total cellular RNA in the TGF-αtreatment groups was elevated from 1.67(P<0.05) to 4.20(P<0.01) fold of the control group as the concentration of TGF-αwere in creased.The 100ng/ml TGF-αtreatment group had significantly higher cellular protein as compared to the control and other TGF-αtreatment groups.It was 1.28 fold(P<0.01) of the control group.And the immigration capability was notable increased by add rhTGF-αcompare with the control group.
     Conclusion:Neutralization of recombinant TGF-αand that present in human colostrums, natural human milk or infant formula milk powder which made mostly by bovine milk medium by TGF-αantibody led to a decrease in in vitro human colon epidermal cell proliferation.These results support that TGF-αderived from different sources has a measurable trophic effect on in vitro human gut epithelial cells.
     Also exogenous TGF-αcan make LoVo cells total cellular RNA and protein increased.It also can make the transference capability increased of LoVo cells
引文
曹劲松.2000.初乳功能性食品.中国轻工业出版社.
    宫春波,张永翠.2003.牛初乳中的营养成分及其保健功能.中国乳业.(4):27-29
    宫春波,张永翠.2003.牛初乳中的营养成分及其保健功能.中国乳业.(4):27-29.
    龚非力.2004.医学免疫学.科学出版社.237-258.
    顾景范,杜寿玢,查良锭等.2003.现代临床营养学(第一版).科学出版社.633-641.
    李圭,单安山.2004.乳源性生长因子及其作用.东北农业大学学报.35(2):129-134
    李静,邓泽元.2005.不同母乳营养成分的比较.33(8):45-47
    李伟明,肖昕,熊爱华,毛晓健,陈新,周晓光.2001.人奶、牛奶和新生儿配方奶中表皮生长因子含量.中国病理生理杂志.17(9):908-910
    李振彪.2000.新生儿胃肠道生长发育研究进展.国外医学儿科学分册.27(1):9-11
    刘红.2006.转化生长因子α对消化性溃疡的修复作用研究进展.国际消化病杂志.26(5):320-322
    刘惠芳,周安国.2001.初乳中的细胞因子及其生物学功能.饲料博览.(12):17-19
    马玉敏,孔彦霞.2000.乳源性表皮生长因子和胰岛素样生长因子1研究进展.中国乳品业.28(2):43-46
    马玉敏,王恬.初乳中生长因子对肠道生长发育的影响.动物科学与动物医学.16(3):14-16
    潘加丽,刘魏,常铮.2006.乳源性生长因子及其生理功能.乳品加工.(8):56-57
    司徒镇强等.1996.细胞培养.西安:世界图书出版公司西安分公司
    苏嚣,杜敏联,赖峰,马华梅.2002.母乳中胰岛素样生长因子1水平对新生儿生长发育的影响.中华儿科杂志.40(9):518-520
    孙晓勉,王维清,刘黎明,贾梅,Kevin Acheson4,郑崇勋.2006.乳母乳汁生长因子变化中国临床营养杂志.14(6):382-38
    王凤英.1995.母乳对婴儿胃肠道抗感染保护机制.国外医学妇产科学分册.22(3):137-140
    王静.2007.乳源性胰岛素样生长因子与新生儿胃肠道发育.中华妇幼临床医学杂志.12(6):347-350
    杨巍,陈庆森,赵林森,庞广昌,胡志和.2007.胰岛素样生长因子对胃肠道影响的研究与展望.中国乳品工业.35(10):38-42
    叶世鸣,陆勤,朱剑琴,朱德煦.1995.人初乳中生长因子的研究.中国应用生理学杂志.11(2):161-163
    曾锦章.1998.胃肠道转化生长因子a的表达及其作用.国外医学.消化系疾病分册.18(4):228-231
    张均田.2000.现代医学实验方法学.协和医科大学联合出版社.
    张俐.1996.表皮生长因子及其受体对胃肠道的作用及应用前景.湖南医学.13(5):300-301
    赵允召.1993.表皮生长因子对胃肠道的作用.国外医学外科学分册.(1):201-204
    周廷冲.1992.多肽生长因子与临床.北京:中国科学技术出版社.686-691
    邹仕庚,郑春田,霍永久.1997.乳中的表皮生长因子及其作用.甘肃畜牧兽医.(5):32-34
    Al-Naffusi AI,Wright NA.2002.The effect of epidermal growth factor(EGF) on cell proliferation of the gastro-intestinal mucosa of rodents.Virchows Arch.40:63.
    Barnard JA,Beauchamp RD,Russell WE,Dubois RN,Coffey RJ.1995.Epidermal growth factor-related peptides and their relevance togastrointestinal pathophysiology.Gastroenterology 108:564-566
    Barnard JA,Beauchamp RD,Russell WE,Dubois RN,Coffey RJ.1995.Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology.Gastroenterology.108:564-580.
    Bines JE,Walker WA.1991.Growth factors and the development of neonatal host defense;in Mestecky J,BlairC,Ogra PL(eds):Immunology of Milk and the Neonate.Adv Exp Med Biol.New York,Plenum Press.vol 310:pp31-39.
    BIRD A R.CROOM WJ.Jejunal.1994.Glucose absorption is enhanced by epidermal growth factor.J Nutr.124:231-240
    Britton JR,Koldovsky O.2003.Development of luminal protein digestion:Implications for biologically activedietary polypeptides.J Pediatr Gastroenterol.9:144-162.
    Buttke TM,McCubrey HA,OwenTC.1993.Use of an aqueous soluble tetrazolium formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.Immunol Methods.157:233-240.
    Carol L.Wagner Donna W.Forsythe Mark T.Wagner.1998.The effect of recombinant TGF-α,human milk,and human milk macrophage media on gut epithelial proliferation is decreased in the presence of a neutralizing TGF-α antibody.Biology Neonate.74:363-371
    Carol L.Wagner Donna W.Forsythe.2002.Effect of Human Milk and Recombinant EGF,TGFα,and IGF-1 On Small Intestinal Cell Proliferation.Advances in Experimnal Medicine and Biology,Short and Long Term Effects of Breast Feding on Child Health..478:373-374
    Carpenter G.1980.Epidermal growth factor is a major growth-promoting agent in human milk.Science.210:198-199.
    Chaet MS,Arya G,Ziegler MM,Warner BW.1994.Epidermal growth factor enhances intestinal adaptation after massive small bowel resection.J Pediatr Surg.29:1035-1039
    CHANG Chun-Ju CHAO Jane C.-J 2002.Effect of human milk and epidermal growth factor on growth of human intestinal Caco-2 Cells.Journal of pediatric gastroenterology and nutrition,34:394-401
    CHANG Chun-Ju CHAO Jane C.-J.2002.Effect of human milk and epidermal growth factor on growth of human intestinal Caco-2 Cells.Journal of pediatric gastroenterology and nutrition,34:394-401
    Chie Hirai,Hiroyuki Ichiba,Mika Saito,Haruo Shintaku.2001.Trophic Effect of Multiple Growth Factor in Amniotic Fluid or Human Milk on Cultured Human Fetal Small Intestinal Cells Joural of Pediatric Gastroenterology and Nutrition.34:524-528
    Connolly JM, Rose DP. 1998. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci. 42:17511-756.
    
    Cross M, Dexter MT. 1991.Growth factors in development, transformation, and tumorigenesis.Cell .6(4):271-273
    
    E J Kelly, S J Newell, K G Brownlee, S M Farmery, C Cullinane, W A Reid, P Jackson, S F Gray, J N Primrose, M Lagopoulos. 1997. Role of epidermal growth factor and transforming growth factor a in the developing stomach. Archives of Disease in Childhood. 76: 158—162
    
    Goldman AS, Goldblum RM. 1995. Defense agents in milk. A. Defense agents in human milk;in Jensen RG (ed): Handbook of Milk Composition. San Diego, Academic Press. pp 727—745.
    
    Goldman AS, Goldblum RM. 1997. Transfer of maternal leukocytes tothe infant by human milk. Curr TopMicrobiol Immunol.222:205—211.
    
    Grosvenor CE, Picciano MF, Baumrucker CR. 1993. Hormones and growth factors in milk.Endocr Rev. 14:710-728.
    
    Hoyt EC, Lund PK, Winesett DE, et al.1996. Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum. Diabetes. 45:434—436
    
    Ichiba H, Kusuda S, Itagane Y, et al. 1992. Measurement of growth promoting activity in human milk using a fetal small intestinal cell line. Biol Neonate. 61:47—53.
    
    Jane C.-J. Chao Sharon Donovan. 1996. Effects of Insulin Insulin-Like Growth Factors and Epidermal Growth Factor on Mitogenesis and Disaccharidase Activity in Rat (IEC-6) Human (FHs 74 Int) Intestinal Cells. Chinese Journal of Physiology.39(4) 253—263
    
    Jatsyk GV, Kuvaeva IB, Gribakin SG.1985. Immunological preparation of the neonatal gastrointestinal tract: The importance of breast feeding. Acta Paediatr Scand. 74:246—249.
    
    Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. 1990. TGF α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell.61:1137— 1140
    
    Karen J. Lessaris Donna W. Forsythe Carol L.Wagner. 2000. Effect of human milk Fortifier on the immunodetection and Molecular Mass Profile of Transforming Growth Factor-Alpha. Biol Neonate .77:156—161
    
    Karnes WE. 1994. Epidermal growth factor and transforming growth factor-ain Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry andPhysiology, New York, Raven Press, pp 553—586.
    
    Karnes WE. 1998. Epidermal growth factor Transforming Growth Factor-Alpha. Gut Peptides: Biocemistry and Physiology. New York, Raven Press, 553—586
    
    Kermorgant S, Walker F, Hormi K, Dresserier V, Lewin MJ, Lehy T. 1992. Developmental expression and functionality of hepatocyte growthfactor and c-Met in human fetal digestive tissues. Gastroenterology. 11(2): 1635—1637
    
    Koldovsky O, Britton J, Grimes J. 1999. Milk-borne epidermal growth factor (EGF) and its processing in developing gastrointestinal tract. Endocr Regul. 25:58—62.
    Koldovsky O. 1980. Hormones in milk. Life Sci .26:1833.
    
    Koldovsky O. 1989. Search for role of milk-borne biologically active peptides for the
    
    Koldovsky 0.1994. Hormonally active peptides in human milk. Acta Paediatr. 402(suppl) :89-92
    
    Koyama S, Podalsky DK. 1989. Differential expression of transforming growth factors a and b in rat intestinal epithelial cells. J Clin Invest. 83:1768—1771
    
    Kretchmer N. 1985. Gastrointestinal and immunologic development. Pediatrics 75:187—188.
    
    Kuitunen OO, Savilahti E, Sarnesto A. 2004. Human alpha-lactalbumin and bovine beta-lactoglobulin absorption in premature infants. Pediatr Res. 37:344—347.
    
    L.L. Chena, J.K. Johanssona, R.R. Hodgesa,, D. Zoukhrib, E. Ghinellia, J.D. Riosa, D.A.Dartta. 2005. Differential effects of the EGF family of growth factors on protein secretion, MAPK activation, and intracellular calcium concentration in rat lacrimal gland. Experimental Eye Research 80: 379—389
    
    LaBrecque DR. 1992. Hepatocyte growth factor—how do I know thee Let me count the ways. Gastroenterology 1992;103:1686—1689
    
    Lemoine NR, Leung HY, Gullick WJ. 1992. Growth factors in the gastrointestinal tract. Gut 3(3): 1297-1299
    
    M. STEPHEN MURPHY, BSC, MD, FRCPI, FRCPCH, DCH. 1998. Growth factors and the gastrointestinal tract. Nutrition. 14(10):771—774
    
    Maiden LT, Novak U, Burgess AW. 1989. Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastrointestinal tract. Int J Cancer. 43:380-384.
    
    Malo C, Menard D. 1982. Influence of epidermal growth factor on the development of suckling mouse intestinal mucosa. Gastroenterology. 83: 28—35.
    
    Markowitz, S.D.Molkentin K et al. 1990. Growth stimulation by coexpression of transforming growth factor-a and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. J.Clin Invest. 86:356—362
    
    Marti U, Burwen SJ, Jones AL. 2004. Biological effects of epidermal growthfactor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology. (9): 126—133
    
    Masaki Okada, Eiji Ohmura, Yoshinobu Kamiya, Hitomi Murakami et al. 1991 Transforming Growth Factor (TGF)-a in Human milk. Life Sciences. 48:115—1156
    
    Mashimo H, Wu DC, Podolsky DK, Fishman MC.1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 27(4):262—265
    
    Massague J. 1987. The TGF-b family of growth and differentiation factors. Cell. 4(9):437—440
    
    McCleary MJ. 1991. Epidermal growth factor: An important constituent of human milk. J Hum Lact .7(3): 123—128.
    
    Miettinen PJ, Berger JE, Meneses J, et al.2005. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature.37(6):337—339
    Nightingale JM, Kamm MA, van der Sijp JR, Ghatei MA, Bloom SR, Lennard-Jones JE. 1996.Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake to gastric emptying. Gut. 3(9):267-269。
    
    Odle J, Zijlstra RT, Donovan SM. 1996. Intestinal effects of milkborne growth factors in neonates of agricultural importance. J Animal Sci. 7(4):2509-2512
    
    Peptrides PE, Hosang M, Shooter EM, Bohlen P. 1984. Transforming growth factors in human milk: Isolation and partial chemical and biological characterization. Proc 7th Int Congr Endocrinol.p1139.
    
    Plaut AG. 1997. Trefoil peptides in the defense of the gastrointestinal tract. N Engl J Med 33(6):506-509
    
    Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM. 1996.
    Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Nat Acad Sci USA. 9(3): 2137—2139
    
    Playford RJ, Wright NA. 1006. Why is epidermal growth factor present in the gut lumen Gut 3(8):303—306
    
    Playford RJ.1005. Peptides and gastrointestinal mucosal integrity. Gut. 37:595-598
    
    Polk DH: 1992. Do breast milk-derived hormones play a role in neonatal development. Early Hum Dev. 29:329-331.
    
    R. Pakkanen, J. Aalto. 1997. Review paper growth factors and antimicrobial factors of bovine colostrums. Dairy Journal. (7):285—297
    
    Rao RK. 1991. Biologically active peptides in the gastrointestinal lumen. Life Sci. 4(8):1685-1688
    
    Raymond J Playford, Christopher E Macdonald, and Wendy S Johnson. 2000. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 72:5—14.
    
    Sandgren EP, Luetteke NC, Plamiter RD, Brinster RL, Lee DC. 1990. Overexpression of TGF α in transgenic mice: induction of epithelialhyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 6(1):1121-1125
    
    Sands BE, Podolsky DK. 2006. The trefoil peptide family. Ann Rev Physiol.. 5 (8): 253—255
    
    Seare NJ, Playford RJ. 1998. Growth factor and gut function. Proc Nutr Soc. 57: 403—408
    
    Seydel AS, Miller JH, Sarac TP, Ryan CK, Sax HC.1996. Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor. Am J Surg.l7(2):267-270
    
    Sibilia M, Wagner EF.2002. Strain dependent epithelial defects mice lacking the EGF receptor. Science. 26(9):234-235
    
    Stig Purup, Mogens Vestergaard, Lone O Pedersen and Kris Sejrsen. 2007. Biological activity of bovine milk on proliferation of human intestinal cells. Journal of Dairy Research. 74: 58—65
    
    Strain AJ.1993. Hepatocyte growth factor: another ubiquitous cytokine. J Endocrinol. 13 (7): 1-8
    
    suckling. JNutr. 119:15431—551.
    
    Taylor RG, Fuller PJ. Humoral regulation of intestinal adaptation. 1994. Baillieres Clin Endocrinol Metab 8:165—169
    
    Thornberg W, Matrisian L, Magun B, Koldovsky O. 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. Am J Physiol. 246:G80—G85.
    
    Threadgill DW, Dlugosz AA, Hansen LA, et al. 1995. Targeted disruption of the mouse EGF receptor: effect of genetic background on mutant phenotype. Science.26(9):230—232
    
    Uehara Y, Minowa O, Mori C, et al. 1995. Placental defect and embryoniclethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 37(3):702—704
    
    Uribe JM, Barrett KE.1997. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology .11(2):255—258
    
    Wagner CL, Anderson DM, Pittard WB. 2004. Special properties of human milk. Clin Pediatr.35:283-293.
    
    Wagner CL, Forsythe DM, 1995. Pittard WB III: Variation in the biochemical forms of transforming growth factor-alpha present in human milk and secreted by human milk macrophages.Biol Neonate. 68:325—333.
    
    Watson H.-S. Hsieh. Jane C.-J. Chao et al. 1997. Effects of epidermal growth factor on total cellular RNA, protein and leucine aminopeptidase in human colon adenocarcinoma (Caco-2) cells.Nutritional Sciences Journal. 22:445—456
    
    Weaver LT, Laker MF, Nelson R. 1984. Intestinal permeability in the newborn. Arch Dis Child. 59:236-241.
    
    Whitman M, Melton DA. 1989. Growth factors in early embryogenesis. AnnRev Cell Biol .5:93—96
    
    Wright NA, Pike C, Elia G. 1990. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:82—85
    
    Yasui W, Ji Z, Kuniyasu K, Ayhan A, Yokozaki H, Ito H, Tahara E.2002. Expression of transforming growth factor alpha in human tissues: Immunohistochemical study and Northern blot analysis. VirchowsArch A Pathol Anat .421:513—519.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700